Skip to content

Clinical trials

Insulin Resistance trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Country / region: Norway Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20081
20093
20101
20112
20121
20132
20141
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Oslo University Hospital4
Norwegian University of Science and Technology3
Atlantis Medical University College2
Marjukka Kolehmainen1
Oslo Metropolitan University1
Pfizer1
Ullevaal University Hospital1
University Hospital of North Norway1
University Hospital, Aker1
University of Bergen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance18
Diabetes Mellitus, Type 25
Obesity5
Diabetes Mellitus4
Glucose Intolerance4
Hypertension3
Overweight3
Body Weight2
Diabetes, Gestational2
Autoimmune Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.